Nuveen »

Elicio Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $70k 18k 3.91

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Elicio Therapeutics

Knoll Capital Management
BlackRock
Caption Management
Vanguard Capital Management
Ikarian Capital
Geode Capital Management
Susquehanna International
Diadema Partners
Toronto-Dominion Bank
Jane Street
Citadel Advisors
Northern Trust
Boothbay Fund Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Elicio Therapeutics